Solas Capital Management, LLC - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.6%.

Quarter-by-quarter ownership
Solas Capital Management, LLC ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,959,008
+2.0%
1,725,567
+19.9%
9.07%
+7.2%
Q2 2023$12,706,617
+18.9%
1,439,028
+12.0%
8.46%
+48.2%
Q1 2023$10,687,398
-11.1%
1,284,543
+2.6%
5.71%
-20.8%
Q4 2022$12,022,925
+31.2%
1,252,388
+10.7%
7.21%
+29.1%
Q3 2022$9,162,000
+39.9%
1,131,167
-3.6%
5.59%
+43.0%
Q2 2022$6,548,000
+2.1%
1,173,516
+2.4%
3.91%
+0.5%
Q1 2022$6,416,000
+68.0%
1,145,796
+32.0%
3.88%
+42.7%
Q4 2021$3,819,000
-53.3%
867,8570.0%2.72%
-52.2%
Q3 2021$8,175,000
+29.2%
867,8570.0%5.69%
+28.1%
Q2 2021$6,327,000
+27.4%
867,857
+8.5%
4.44%
+6.2%
Q1 2021$4,968,000
-16.6%
800,0000.0%4.18%
-8.1%
Q4 2020$5,960,000
+22.9%
800,0000.0%4.55%
-2.1%
Q3 2020$4,848,000
-39.5%
800,000
-16.7%
4.64%
-37.2%
Q2 2020$8,016,000
+40.6%
960,0000.0%7.40%
+19.8%
Q1 2020$5,702,000
-9.6%
960,000
-1.2%
6.17%
+1.8%
Q4 2019$6,307,000
+39.0%
971,795
+3.0%
6.06%
+29.2%
Q3 2019$4,537,000
+33.4%
943,200
+11.0%
4.69%
+35.1%
Q2 2019$3,400,000849,9793.47%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders